NEWS CENTER

The field of Alzheimer’s disease (AD) diagnostics has recently reached two major milestones—globally and in China—reshaping both neuroscience research and the clinical landscape. On one hand, the Elecsys pTau217 blood test, jointly developed by Roche and Lilly, has received FDA

——Nature Research | Engineered Probiotic GIFT Achieves Closed-Loop Glycaemic Control in Diabetes, with Efficacy Comparable to Semaglutide and an Improved Safety Profile Title: Glucose-responsive probiotics for glycaemic modulation in mice and monkeys DOI: 10.1038/s41586-026

——Yale University’s Reinisch team reports two complementary studies: uncovering the full pathway of non-vesicular lipid transfer and revealing the molecular mechanisms underlying Parkinson’s disease and chorea I. Research Background: VPS13—A Key “Bridge&rdquo

A study published in Nature Cancer revealed that the neurotransmitter GABA can “reprogram” myeloid-derived suppressor cells (MDSCs) in females, creating an immunosuppressive environment that suppresses anti-tumor immunity. Blocking this pathway significantly prolonged survival only in fe

Good morning or afternoon, everyone. Glancing out at river views or bustling street traffic, do you feel anxious over last night’s insomnia or struggling to get out of bed this morning? Worry not, a landmark new research published in Nature may resolve your sleep-related concerns. Released on May 13

Recently, a review titled "Navigating the Clinical Progress of Antibody-Drug Conjugates" was published in Cell, summarizing the breakthroughs and future directions of antibody-drug conjugates (ADCs). The article emphasizes that Conjugates technology and linker chemistry are fundamental to determinin